Affiliation:
1. 3rd Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Sotiria Chest Disease Hospital,
Athens, Greece
2. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Abstract
Abstract:
Cardiovascular disease remains the main cause of human morbidity and mortality in developed countries.
Microparticles (MPs) are small vesicles originating from the cell membrane as a result of various stimuli
and particularly of biological processes that constitute the pathophysiology of atherosclerosis, such as endothelial
damage. They form vesicles that can transfer various molecules and signals to remote target cells without
direct cell-to-cell interaction. Circulating microparticles have been associated with cardiovascular diseases.
Therefore, many studies have been designed to further investigate the role of microparticles as biomarkers for
diagnosis, prognosis, and disease monitoring. To this concept, the pro-thrombotic and atherogenic potential of
platelets and endothelial-derived MPs have gained research interest, especially concerning accelerated atherosclerosis
and triggering as well as prognosis of an acute coronary syndrome. MPs, especially those of endothelial
origin, have been investigated in different clinical scenarios of heart failure and in association with left ventricular
loading conditions. Finally, most cardiovascular risk factors present unique features in the circulating
MPs population, highlighting their pathophysiologic link to cardiovascular disease progression. In this review
article, we present a synopsis of the biogenesis and characteristics of microparticles, as well as the most recent
data concerning their implication in cardiovascular settings.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献